Literature DB >> 8824367

Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia.

M M Crane1, S S Strom, S Halabi, E L Berman, J J Fueger, M R Spitz, M J Keating.   

Abstract

Many bone marrow cytogenetic abnormalities in acute myelogenous leukemia (AML) are tumor specific, clonal, nonrandom, and related to prognosis; it has been hypothesized that they may be markers of exposure to etiological agents. A previous report from our institution revealed several such associations; the purpose of the current study was to determine whether previous findings were present in a new group of patients. Subjects included 84 newly diagnosed AML patients (French-American-British M1 and M2); exposure data were gathered using self-report questionnaires at the time of registration. Two sets of comparisons were made: (a) patients with all (AA) or some (AN) cytogenetically abnormal cells versus those with normal karyotypes (NN) and (b) patients with specific abnormalities [-5/5q-, -7/7q-, +8, t(8;21)] versus all others. Odds ratios (ORs) were 4.64 for the association between prior cytotoxic therapy and -5/5q- and 6.38 for the association with -7/7q-, but were <1.00 for +8 and t(8;21). There were no ORs > 2.0 for specific abnormalities in any of the other exposures evaluated (cigarette smoking, alcohol use, occupational exposure to organic chemicals, paints, or pesticides/herbicides), with the exception of exposure to paints and -7/7q- (OR, 7.50). The ORs for AA/AN versus NN patients were 1.43 and 3.81 for smoking and alcohol use, and weak dose-response trends were present. The most consistent positive associations between the two series were for prior cytotoxic therapy (-5/5q-; -7/7q-), cigarette smoking (AA/AN versus NN) and alcohol use (AA/AN versus NN). Reasoning from the known association between prior cytotoxic therapy and -7/7q-, we would have predicted relatively high ORs (> 4.0) if specific abnormalities acted as markers for the exposures assessed, but none were present. However, in both series, AA/AN patients were more likely to smoke and use alcohol than were NN patients, and weak dose-response patterns were present for both. This finding suggests that both smoking and alcohol use may play a role in the pathogenesis of cytogenetic abnormalities in AML-M1/M2; however, the mechanism by which they work and whether they are involved in the etiology of these diseases remain unclear.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824367

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Fluorescence in situ hybridization is necessary to detect an association between chromosome aberrations and polycyclic aromatic hydrocarbon exposure in utero and reveals nonrandom chromosome involvement.

Authors:  Kirsti A Bocskay; Manuela A Orjuela; Deliang Tang; Xinhua Liu; Dorothy Warburton; Frederica P Perera
Journal:  Environ Mol Mutagen       Date:  2007-03       Impact factor: 3.216

2.  Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype.

Authors:  Catherine Metayer; Luoping Zhang; Joseph L Wiemels; Karen Bartley; Joshua Schiffman; Xiaomei Ma; Melinda C Aldrich; Jeffrey S Chang; Steve Selvin; Cecilia H Fu; Jonathan Ducore; Martyn T Smith; Patricia A Buffler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-12       Impact factor: 4.254

3.  Genetic abnormalities and challenges in the treatment of acute myeloid leukemia.

Authors:  C Chandra Kumar
Journal:  Genes Cancer       Date:  2011-02

4.  Smoking adversely affects survival in acute myeloid leukemia patients.

Authors:  Ramya Varadarajan; Andrea S Licht; Andrew J Hyland; Laurie A Ford; Sheila N J Sait; Annemarie W Block; Maurice Barcos; Maria R Baer; Eunice S Wang; Meir Wetzler
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

5.  Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.

Authors:  Ramya Varadarajan; LaurieAnn Ford; Sheila N J Sait; AnneMarie W Block; Maurice Barcos; Paul K Wallace; Nithya Ramnath; Eunice S Wang; Meir Wetzler
Journal:  Leuk Res       Date:  2009-01-31       Impact factor: 3.156

6.  International study of factors affecting human chromosome translocations.

Authors:  Alice J Sigurdson; Mina Ha; Michael Hauptmann; Parveen Bhatti; Radim J Sram; Olena Beskid; E Janet Tawn; Caroline A Whitehouse; Carita Lindholm; Mimako Nakano; Yoshiaki Kodama; Nori Nakamura; Irena Vorobtsova; Ursula Oestreicher; Günther Stephan; Lee C Yong; Manfred Bauchinger; Ernst Schmid; Hai Won Chung; Firouz Darroudi; Laurence Roy; Phillipe Voisin; Joan F Barquinero; Gordon Livingston; David Blakey; Isamu Hayata; Wei Zhang; Chunyan Wang; L Michelle Bennett; L Gayle Littlefield; Alan A Edwards; Ruth A Kleinerman; James D Tucker
Journal:  Mutat Res       Date:  2008-02-02       Impact factor: 2.433

7.  Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation.

Authors:  Jessica R B Musselman; Cindy K Blair; James R Cerhan; Phuong Nguyen; Betsy Hirsch; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2013-05-02       Impact factor: 2.984

8.  Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.

Authors:  A V Moorman; E Roman; R A Cartwright; G J Morgan
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

9.  Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

Authors:  Hussein Fayyad-Kazan; Nizar Bitar; Mehdi Najar; Philippe Lewalle; Mohammad Fayyad-Kazan; Rabih Badran; Eva Hamade; Ahmad Daher; Nader Hussein; Rim ElDirani; Fadwa Berri; Luc Vanhamme; Arsène Burny; Philippe Martiat; Redouane Rouas; Bassam Badran
Journal:  J Transl Med       Date:  2013-02-07       Impact factor: 5.531

10.  Biomarkers of leukemia risk: benzene as a model.

Authors:  M T Smith; L Zhang
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.